Buy Stocks Easy | About Us
April 23, 2021
Buy Stocks Easy | Online Stocks

TRIL


Buy Trillium Therapeutics Inc. Stock (symbol: TRIL) Easy Online

Company Name: Trillium Therapeutics Inc.

Symbol: TRIL

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2005

TRIL Current Share Price

Today's TRIL ( Trillium Therapeutics Inc. ) opening price: $0.6399

Yesterday's TRIL ( Trillium Therapeutics Inc. ) closing price: $0.5969

Trillium Therapeutics Inc. Stock ( symbol: TRIL ) Price Chart since IPO (2005):

12 Months Trillium Therapeutics Inc. Stock ( symbol: TRIL ) Price Chart

Popular Questions about Trillium Therapeutics Inc. Public Stock ( TRIL )

A: Trillium Therapeutics Inc. stock symbol (also called stock or share ticker) is TRIL

A: Trillium Therapeutics Inc. IPO (Initial Public Offering) took place on 2005

A: Trillium Therapeutics Inc.'s stock (TRIL symbol) price at ther IPO (initial Public Offering) was $0.6399

Q: Is TRIL stock worth buying at the moment?

A: The TRIL stock performance since 2019 are rather disappointing. If you had bought 1 share of Trillium Therapeutics Inc. stock (symbol: TRIL) at the beginning of 2019, at the opening share price of $1.8030, you would be left with exactly $0.6399 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy Trillium Therapeutics Inc. Stock Easy Online

Trillium Therapeutics Inc. Stock Ticker Price Chart since IPO:





Trillium Therapeutics Inc. Stock Price Yesterday



 


Trillium Therapeutics Inc. Stock Price – Last Week




 


Trillium Therapeutics Inc. Stock Price – Last Month




 


Trillium Therapeutics Inc. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1947076/0/en/Trillium-Therapeutics-Reports-Third-Quarter-2019-Financial-Results-and-Provides-Corporate-Update.html
                            

                                
Trillium Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

                                
                                
TORONTO, Nov.  14, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/22/1933273/0/en/Trillium-Therapeutics-Announces-Corporate-Restructuring-and-Provides-CD47-Program-Update.html
                            

                                
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update

                                
                                
TORONTO, Oct.  22, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/08/1926350/0/en/Trillium-Granted-180-Day-Extension-by-NASDAQ-to-Regain-Compliance-With-Minimum-Bid-Price-Rule.html
                            

                                
Trillium Granted 180-Day Extension by NASDAQ to Regain Compliance With Minimum Bid Price Rule

                                
                                
TORONTO, Oct.  08, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/25/1920492/0/en/Trillium-Therapeutics-Appoints-Jan-Skvarka-as-President-and-Chief-Executive-Officer.html
                            

                                
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer

                                
                                
Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Repor...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911399/0/en/Trillium-Therapeutics-To-Present-At-Investor-Conference.html
                            

                                
Trillium Therapeutics To Present At Investor Conference

                                
                                
TORONTO, Sept.  05, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/07/1967258/0/en/Trillium-Therapeutics-Provides-Update-on-Its-TTI-621-and-TTI-622-CD47-Programs.html
                            

                                
Trillium Therapeutics Provides Update on Its TTI-621 and TTI-622 CD47 Programs

                                
                                
CAMBRIDGE, Mass., Jan.  07, 2020  (GLOBE NEWSWIRE) -- Trillium Ther...


                            

                        
                    

                


                            

                    


                        
                            http://www.zacks.com/stock/news/700426/is-the-options-market-predicting-a-spike-in-trillium-tril-stock
                            

                                
Is the Options Market Predicting a Spike in Trillium (TRIL) Stock?

                                
                                
Investors need to pay close attention to Trillium (TRIL) stock base...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/11/14/1947076/0/en/Trillium-Therapeutics-Reports-Third-Quarter-2019-Financial-Results-and-Provides-Corporate-Update.html
                            

                                
Trillium Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update

                                
                                
TORONTO, Nov.  14, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/22/1933273/0/en/Trillium-Therapeutics-Announces-Corporate-Restructuring-and-Provides-CD47-Program-Update.html
                            

                                
Trillium Therapeutics Announces Corporate Restructuring and Provides CD47 Program Update

                                
                                
TORONTO, Oct.  22, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/08/1926350/0/en/Trillium-Granted-180-Day-Extension-by-NASDAQ-to-Regain-Compliance-With-Minimum-Bid-Price-Rule.html
                            

                                
Trillium Granted 180-Day Extension by NASDAQ to Regain Compliance With Minimum Bid Price Rule

                                
                                
TORONTO, Oct.  08, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics ...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/25/1920492/0/en/Trillium-Therapeutics-Appoints-Jan-Skvarka-as-President-and-Chief-Executive-Officer.html
                            

                                
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer

                                
                                
Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) Repor...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/09/05/1911399/0/en/Trillium-Therapeutics-To-Present-At-Investor-Conference.html
                            

                                
Trillium Therapeutics To Present At Investor Conference

                                
                                
TORONTO, Sept.  05, 2019  (GLOBE NEWSWIRE) -- Trillium Therapeutics...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.